Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea.
10.5468/ogs.2018.61.3.319
- Author:
Hye joo LEE
1
;
Wonkyo SHIN
;
Yun Jeong JANG
;
Chel Hun CHOI
;
Jeong Won LEE
;
Duk Soo BAE
;
Byoung Gie KIM
Author Information
1. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bgkim@skku.edu
- Publication Type:Original Article
- Keywords:
Placental site trophoblastic tumor;
Gestational trophoblastic disease;
Prognosis
- MeSH:
Amenorrhea;
Chorionic Gonadotropin;
Diagnosis;
Electronic Health Records;
Ethics Committees, Research;
Female;
Follow-Up Studies;
Gestational Trophoblastic Disease;
Humans;
Hysterectomy;
Korea*;
Medical Records;
Neoplasm Metastasis;
Pregnancy;
Prognosis;
Trophoblastic Tumor, Placental Site*;
Uterine Hemorrhage;
Uterus
- From:Obstetrics & Gynecology Science
2018;61(3):319-327
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Placental site trophoblastic tumor (PSTT) is the rarest form of gestational trophoblastic disease (GTD) and the optimum management is still controversial. In this study, we analyzed the clinical features, treatment, and outcomes of 6 consecutive patients with PSTT treated in our institution. METHODS: The electronic medical record database of Samsung Medical Center was screened to identify patients with PSTT from 1994 to 2017. Medical records for the details of each patient's clinical features and treatment were extracted and reviewed. This study was approved Institutional Review Board of our hospital. RESULTS: A total of 418 cases of GTD, 6 (1.4%) patients with PSTT were identified. The median age of the patients was 31 years. The antecedent pregnancy was term in all 5 cases with available antecedent pregnancy information and the median interval from pregnancy to diagnosis of PSTT was 8 months. The median titer of serum beta human chorionic gonadotropin (β-hCG) at diagnosis was 190.9 mIU/mL. Five (83.3%) patients presented with irregular vaginal bleeding and one (16.7%) had amenorrhea. All patients had disease confined to the uterus without metastasis at diagnosis and were successfully treated by hysterectomy alone. All of them were alive without disease during the follow-up period. CONCLUSION: In this study, we observed low level serum β-hCG titer and irregular vaginal bleeding with varying interval after antecedent term pregnancy were most common presenting features of PSTT. In addition, we demonstrated hysterectomy alone was successful for the treatment of stage I disease of PSTT.
